TGFB1 and diabetes mellitus: In mice treated with empagliflozin, the diabetes-induced upregulation of Tgfβ1 and Cd14 was absent and there was a trend for reduced Fn1 expression compared to vehicle-treated db/db mice (P = 0.059, Fig. 9b,d,e).